Antiviral cellular therapy for T-cell reconstitution (donor-derived virus-specific T cells)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Antiviral cellular therapy for T-cell reconstitution (donor-derived virus-specific T cells), covering 2025-05-11 to 2025-05-11. Get the full timeline:
Most recent: Clinical Trial Update: Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]